Piascledin® 300 efficacy in the management of osteoarthritis: proved in clinical trials, confirmed by European practice

Bortkevych O.P.

• SI «NSC «Institute of Cardiology M.D. Strazhesko» NAMS of Ukraine», Kyiv

Summary. The problem of osteoarthritis management and its new approaches are discussed in the article. The new SYSADOA preparation Piascledin® 300, which had been used worldwide for hip and knee osteoarthritis, has appeared in Ukraine. European evidence based data for Piascledin® 300 efficacy and advantages of its administration are presented in the article.